152 related articles for article (PubMed ID: 1278017)
1. [Letter: Clofibrate and clofibrate-inositolnicotinate].
Rahlfs VW
Dtsch Med Wochenschr; 1976 Jun; 101(25):975. PubMed ID: 1278017
[No Abstract] [Full Text] [Related]
2. [The effect of a lipid-reducing clofibrate-inositolnicotinate combination compared to clofibrate. A double-blind study].
Schäfer B; Kluthe R
Med Welt; 1975 Apr; 26(14):655-63. PubMed ID: 1099394
[No Abstract] [Full Text] [Related]
3. [The problem of type changes in hyperlipoproteinemia (type IIb, IV, V) under clofibrate and m-inositol nicotinate therapy].
Schwartzkopff W; Zschiedrich M
Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():825-9. PubMed ID: 196436
[No Abstract] [Full Text] [Related]
4. [The management of hyperlipoproteinemia with Liproreduct].
Fenster R
Ther Ggw; 1974 May; 113(5):813-24. PubMed ID: 4603893
[No Abstract] [Full Text] [Related]
5. [New drug combination for medical management of hyperlipemia: clinical study].
Fischer M; Falkensammer C
Int J Clin Pharmacol Biopharm; 1977 Dec; 15(12):585-9. PubMed ID: 340391
[TBL] [Abstract][Full Text] [Related]
6. [Letter: Clofibrate and clofibrate-inositolnicotinate].
Wilke H; Frahm H
Dtsch Med Wochenschr; 1976 Aug; 101(33):1236. PubMed ID: 947731
[No Abstract] [Full Text] [Related]
7. [Combination or monotherapy of hyperlipoproteinemia typus IIb, IV, V with clofibrate and m-inositolnicotinate or clofibrinic acid (author's transl)].
Schwartzkopff W; Zschiedrich M
Med Klin; 1978 Feb; 73(7):231-9. PubMed ID: 203832
[TBL] [Abstract][Full Text] [Related]
8. [Lipid-lowering effect of a combination of clofibrate and DL-alpha-tocopherol nicotinate in unselected hyperlipemic patients].
Gniwotta E; Herter B
ZFA (Stuttgart); 1977 Apr; 53(10):565-8. PubMed ID: 324162
[No Abstract] [Full Text] [Related]
9. [Indications for lipid reducing drugs].
Faergeman AO
Ugeskr Laeger; 1976 Jan; 138(5):291-3. PubMed ID: 1251496
[No Abstract] [Full Text] [Related]
10. [Ambulatory treatment of hyperlipemias].
Stanulović D; Stojsić D
Med Pregl; 1973; 26(9):367-9. PubMed ID: 4793820
[No Abstract] [Full Text] [Related]
11. [Drugs which decrease serum lipids].
Oye I
Tidsskr Nor Laegeforen; 1973 Jan; 93(1):32-3. PubMed ID: 4691222
[No Abstract] [Full Text] [Related]
12. Clofibrate and nicotinic acid.
Hoffer A
Can Med Assoc J; 1972 Sep; 107(6):488 passim. PubMed ID: 5057001
[No Abstract] [Full Text] [Related]
13. [Effect of a new lipid-reducing preparation in case of hyperlipoproteinemia].
Knüchel F
Med Welt; 1974 Oct; 25(43):1766-9. PubMed ID: 4419179
[No Abstract] [Full Text] [Related]
14. [Pharmacological treatment of hyperlipoproteinemias--theory and practice].
Frisk-Holmberg M
Lakartidningen; 1974 Aug; 71(34):3083-6. PubMed ID: 4410383
[No Abstract] [Full Text] [Related]
15. Lipid-lowering drugs.
Med Lett Drugs Ther; 1975 Jun; 17(12):49-50. PubMed ID: 1128443
[No Abstract] [Full Text] [Related]
16. [The lipid-reducing efficiency of a clofibrate-inositolnicotinate combination in comparison with clofibrate. The wrong use of statistical methods--presented on an example from clinical research].
Haase W; Kluthe R; Schäfer B
Med Welt; 1975 Nov; 26(47):2157-9. PubMed ID: 1105056
[No Abstract] [Full Text] [Related]
17. [Arteriosclerosis--nicotinic acid therapy. 10. Combination therapy in hyperlipemia].
Hansen PF
Lakartidningen; 1971 Apr; 68(15):1769-72. PubMed ID: 5577252
[No Abstract] [Full Text] [Related]
18. [Arteriosclerosis--nicotinic acid therapy. 8. Treatment of hyperlipemia].
Sigroth K
Lakartidningen; 1971 Apr; 68(15):1765-7. PubMed ID: 5577250
[No Abstract] [Full Text] [Related]
19. [Arteriosclerosis--nicotinic acid therapy. 2. Alterations in serum lipoproteins. Diagnosis, therapy].
Gustafson A
Lakartidningen; 1971 Apr; 68(15):1744-5 passim. PubMed ID: 5577244
[No Abstract] [Full Text] [Related]
20. [Therapy of essential hyperlipidemias].
Schlierf G; Kahlke W
Minerva Med; 1972 Feb; 63(14):853-5. PubMed ID: 5012560
[No Abstract] [Full Text] [Related]
[Next] [New Search]
